AGP Executive Report
Last update: 8 hours agoPostpartum Health: A California study of more than 2 million deliveries found that pregnant women diagnosed with cannabis use disorder had a 40% higher risk of psychiatric emergency visits in the year after birth than those without the disorder. Researchers say the findings highlight a need for support during pregnancy and postpartum. Hemp Rules: Wisconsin’s hemp industry faces a Dec. 11 federal THC limit that could affect products including full-spectrum CBD oils, putting businesses and consumers’ access at risk. A veteran’s commentary argues that testing, clear labels and age limits could address safety without cutting off legal options. CBD Buying Guide: A new guide offers tips for reading CBD product labels and spotting marketing claims. Cannabis Pain Trial: A U.S. clinical trial will test VER-01, a cannabis-based medicine containing THC, for persistent back pain; it would be the first FDA-approved cannabis-based pain treatment if trials succeed and the agency grants approval.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
